IRIS Accounts Production v24.3.2.46 06960233 Board of Directors 1.8.23 31.7.24 31.7.24 false true false false false true false 770 2090 30148 30181 29287 31501 1631 770 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pureutr:tonnesutr:kWh069602332023-07-31069602332024-07-31069602332023-08-012024-07-31069602332022-07-31069602332022-08-012023-07-31069602332023-07-3106960233ns15:EnglandWales2023-08-012024-07-3106960233ns14:PoundSterling2023-08-012024-07-3106960233ns10:Director12023-08-012024-07-3106960233ns10:PrivateLimitedCompanyLtd2023-08-012024-07-3106960233ns10:SmallEntities2023-08-012024-07-3106960233ns10:AuditExempt-NoAccountantsReport2023-08-012024-07-3106960233ns10:SmallCompaniesRegimeForDirectorsReport2023-08-012024-07-3106960233ns10:SmallCompaniesRegimeForAccounts2023-08-012024-07-3106960233ns10:FullAccounts2023-08-012024-07-310696023312023-08-012024-07-3106960233ns10:Director2422023-07-3106960233ns10:Director2422022-07-3106960233ns10:Director2422023-08-012024-07-3106960233ns10:Director2422022-08-012023-07-3106960233ns10:Director2422024-07-3106960233ns10:Director2422023-07-3106960233ns10:Director22023-08-012024-07-3106960233ns10:Director32023-08-012024-07-3106960233ns10:RegisteredOffice2023-08-012024-07-3106960233ns5:CurrentFinancialInstruments2024-07-3106960233ns5:CurrentFinancialInstruments2023-07-3106960233ns5:ShareCapital2024-07-3106960233ns5:ShareCapital2023-07-3106960233ns5:SharePremium2024-07-3106960233ns5:SharePremium2023-07-3106960233ns5:RetainedEarningsAccumulatedLosses2024-07-3106960233ns5:RetainedEarningsAccumulatedLosses2023-07-3106960233ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-07-3106960233ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-08-012024-07-3106960233ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2024-07-3106960233ns5:DevelopmentCostsCapitalisedDevelopmentExpenditure2023-07-3106960233ns5:PlantMachinery2023-07-3106960233ns5:MotorVehicles2023-07-3106960233ns5:ComputerEquipment2023-07-3106960233ns5:PlantMachinery2023-08-012024-07-3106960233ns5:MotorVehicles2023-08-012024-07-3106960233ns5:ComputerEquipment2023-08-012024-07-3106960233ns5:PlantMachinery2024-07-3106960233ns5:MotorVehicles2024-07-3106960233ns5:ComputerEquipment2024-07-3106960233ns5:PlantMachinery2023-07-3106960233ns5:MotorVehicles2023-07-3106960233ns5:ComputerEquipment2023-07-3106960233ns5:WithinOneYearns5:CurrentFinancialInstruments2024-07-3106960233ns5:WithinOneYearns5:CurrentFinancialInstruments2023-07-31069602331ns10:Director12023-07-31069602331ns10:Director12022-07-31069602331ns10:Director12023-08-012024-07-31069602331ns10:Director12022-08-012023-07-31069602331ns10:Director12024-07-31069602331ns10:Director12023-07-31069602333ns10:Director32023-07-31069602333ns10:Director32022-07-31069602333ns10:Director32023-08-012024-07-31069602333ns10:Director32022-08-012023-07-31069602333ns10:Director32024-07-31069602333ns10:Director32023-07-31
REGISTERED NUMBER: 06960233 (England and Wales)















UNAUDITED FINANCIAL STATEMENTS FOR THE YEAR ENDED 31 JULY 2024

FOR

HEALTHY SUPPLIES LIMITED

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)






CONTENTS OF THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024




Page

Company Information 1

Balance Sheet 2

Notes to the Financial Statements 3


HEALTHY SUPPLIES LIMITED

COMPANY INFORMATION
FOR THE YEAR ENDED 31 JULY 2024







DIRECTORS: Ms R M Manahai
Ms A W Rosinska
D Samantzopoulos





REGISTERED OFFICE: Unit 1 South Coast House
Lancing Business Park
35 Chartwell Road
Lancing
West Sussex
BN15 8TU





REGISTERED NUMBER: 06960233 (England and Wales)





ACCOUNTANTS: Galloways Accounting (Hove) Limited
15 West Street
Brighton
East Sussex
BN1 2RL

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

BALANCE SHEET
31 JULY 2024

2024 2023
Notes £    £    £    £   
FIXED ASSETS
Intangible assets 3 - 1,705
Tangible assets 4 72,220 90,621
72,220 92,326

CURRENT ASSETS
Stocks 5 455,126 357,013
Debtors 6 125,829 108,495
Cash at bank and in hand 225,720 267,134
806,675 732,642
CREDITORS
Amounts falling due within one year 7 322,313 263,920
NET CURRENT ASSETS 484,362 468,722
TOTAL ASSETS LESS CURRENT
LIABILITIES

556,582

561,048

PROVISIONS FOR LIABILITIES 17,498 22,403
NET ASSETS 539,084 538,645

CAPITAL AND RESERVES
Called up share capital 16,000 16,000
Share premium 25,200 25,200
Retained earnings 497,884 497,445
SHAREHOLDERS' FUNDS 539,084 538,645

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 July 2024.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 July 2024 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 21 March 2025 and were signed on its behalf by:





Ms R M Manahai - Director


HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 JULY 2024

1. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, net of discounts and value added taxes. Turnover includes revenue earned from the sale of goods and form the rendering of services. Turnover is reduced for estimated customer returns, rebates and other similar allowances.

Sale of Goods
Turnover from the sale of goods is recognised when the significant risks and rewards of ownership of the goods has transferred to the buyer. This is usually at the point that the customer has signed for the delivery of the goods.

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax
Deferred taxation is provided in full on timing differences which represent a liability at the balance sheet date, at rates expected to apply when they crystallise based on current tax rates and law. Timing differences arise from the inclusion of items of in-come and expenditure in taxation computations in periods different from those in which they are included in financial statements. Deferred tax assets and liabilities are not discounted.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

2. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 26 (2023 - 25 ) .

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

3. INTANGIBLE FIXED ASSETS
Development
costs
£   
COST
At 1 August 2023
and 31 July 2024 10,821
AMORTISATION
At 1 August 2023 9,116
Amortisation for year 1,705
At 31 July 2024 10,821
NET BOOK VALUE
At 31 July 2024 -
At 31 July 2023 1,705

4. TANGIBLE FIXED ASSETS
Plant and Motor Computer
machinery vehicles equipment Totals
£    £    £    £   
COST
At 1 August 2023 199,009 550 28,146 227,705
Additions 11,672 - 2,862 14,534
At 31 July 2024 210,681 550 31,008 242,239
DEPRECIATION
At 1 August 2023 108,768 550 27,766 137,084
Charge for year 31,898 - 1,037 32,935
At 31 July 2024 140,666 550 28,803 170,019
NET BOOK VALUE
At 31 July 2024 70,015 - 2,205 72,220
At 31 July 2023 90,241 - 380 90,621

5. STOCKS
2024 2023
£    £   
Stocks 455,126 357,013

6. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade debtors 4,690 1,892
Other debtors 71,917 49,240
Directors' loan accounts 1,682 1,362
VAT 19,204 16,061
Prepayments and accrued income 28,336 39,940
125,829 108,495

HEALTHY SUPPLIES LIMITED (REGISTERED NUMBER: 06960233)

NOTES TO THE FINANCIAL STATEMENTS - continued
FOR THE YEAR ENDED 31 JULY 2024

7. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
2024 2023
£    £   
Trade creditors 139,605 134,905
Tax 99,877 57,842
Social security and other taxes 16,307 15,129
Other creditors 66,092 51,578
Accruals and deferred income 432 4,466
322,313 263,920

8. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31 July 2024 and 31 July 2023:

2024 2023
£    £   
Ms R M Manahai
Balance outstanding at start of year 593 487
Amounts advanced 9,581 6,575
Amounts repaid (10,123 ) (6,469 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 51 593

D Samantzopoulos and Ms A W Rosinska
Balance outstanding at start of year 770 2,090
Amounts advanced 30,148 30,181
Amounts repaid (29,287 ) (31,501 )
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 1,631 770

These loans are interest free and repayable on demand. Both loans were repaid within 9 months of the year end.

9. ULTIMATE CONTROLLING PARTY

The ultimate controlling party is D Samantzopoulos.

This was by virtue of his 51% holding of the issued share capital.